Biologics Supplier for Orthopedic Practices in Kansas City, MO

How orthopedic practices typically vet a biologics supplier

Orthopedic groups and surgery centers that add a regenerative biologics line generally start the same way: they ask a supplier for its donor eligibility and screening documentation, a certificate of analysis for the specific lot under consideration, and a summary of how tissue is processed and tested before release. Practices in the region commonly route this request through a practice administrator or medical director rather than an individual physician, since the documentation supports both purchasing and compliance records.

Precision Biologics provides this documentation to verified accounts on request, including sterility testing results and lot-specific release criteria. We do not provide clinical guidance on how a product should be used; intended use and regulatory classification for a specific procedure remain determinations for the practice and its counsel.

• Certificate of analysis per lot
• Donor eligibility and screening summary
• Processing and sterility testing documentation

NPI-verified accounts and ordering

Orders are limited to licensed professionals and the accounts that represent them. Setting up an account requires an NPI number, which Precision Biologics checks against the NPPES registry before activating ordering access. This step keeps purchasing limited to licensed clinics, medspas operating under physician supervision, and physicians, consistent with how these products are distributed nationally.

Cold-chain receiving for Midwest practices

Cryopreserved Wharton's jelly and exosome products ship overnight on dry ice in validated containers and are stored at -80 degrees C on arrival. Practices receiving shipments should plan for staff to accept and immediately transfer product to appropriate storage, and to record the lot number against the shipment manifest on arrival.

Lyophilized formats do not require cryogenic storage and can simplify receiving for practices without freezer capacity, though they should still be logged by lot at intake.

Medical director and state board verification

Before adding any biologics line, Missouri practices should confirm with their medical director, the Missouri state medical board, and their own legal counsel how the intended use of a given product is classified under applicable federal and state rules. Precision Biologics does not advise on clinical use, dosing or procedures, and our account documentation is intended to support that internal review rather than substitute for it.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.